Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Shareholders Equity (Quarterly) : 239.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 239.17M |
| March 31, 2026 | 273.16M |
| December 31, 2025 | 305.26M |
| September 30, 2025 | 332.00M |
| June 30, 2025 | 167.88M |
| March 31, 2025 | 201.42M |
| December 31, 2024 | 164.76M |
| September 30, 2024 | 196.20M |
| June 30, 2024 | 261.31M |
| March 31, 2024 | 324.44M |
| December 31, 2023 | 433.43M |
| September 30, 2023 | 418.40M |
| Date | Value |
|---|---|
| June 30, 2023 | 386.36M |
| March 31, 2023 | 352.65M |
| December 31, 2022 | 340.61M |
| September 30, 2022 | 144.03M |
| June 30, 2022 | 192.79M |
| March 31, 2022 | 240.95M |
| December 31, 2021 | 88.18M |
| September 30, 2021 | 115.28M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 5.337M |
| September 30, 2020 | 0.00 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 85.19B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| EyePoint, Inc. | 166.41M |
| Bristol Myers Squibb Co. | 22.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.56M |
| Total Liabilities (Quarterly) | 25.40M |
| Debt to Equity Ratio | 0.022 |
| Current Ratio | 12.12 |
| Net Debt Paydown Yield | -0.04% |